Tatiana D.
- Country
- Belgium
- Department
- radiotherapy
Research Overview
- Phase III Evaluation of Xevinapant and Radiotherapy Versus Placebo and Radiotherapy in High-Risk Resected Squamous Cell Carcinoma of the Head and Neck
- Evaluation of Swallowing Outcomes and Quality of Life in Advanced Oropharyngeal Cancer Patients Undergoing Prophylactic Versus Reactive PEG Tube Placement with Cisplatin and Drug Combination
Data & Insights
Has run more than one trial at 1 of 87 partner sites.
Specializations
Head and Neck Oncology
The investigator specializes in treating advanced head and neck cancers, with particular emphasis on squamous cell carcinoma and oropharyngeal cancer.
- Post-surgical cancer management
- Advanced radiotherapy applications
- Treatment of locally advanced disease
Expertise includes innovative therapeutic approaches for high-risk head and neck cancer patients.
Supportive Care
Focuses on quality of life management for head and neck cancer patients, with specific attention to swallowing function preservation and rehabilitation.
- Dysphagia management
- Gastrostomy tube placement strategies
- Patient-reported outcomes assessment
Specializes in optimizing supportive care interventions during chemoradiotherapy treatment.
Combined Modality Treatment
Expert in multimodal therapy approaches, integrating chemoradiotherapy with other treatment modalities for head and neck cancer.
- Definitive chemoradiotherapy protocols
- Novel therapeutic combinations
- Risk-adapted treatment strategies
Focuses on developing personalized treatment approaches for complex cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.